"Pardee UNC Health Care is a not-for-profit health care system that was founded in 1953 and is managed by UNC Health Care. It is the first and only hospital in North Carolina to be accredited with the International Organization for Standardization (ISO 9001:2008) for quality health care standards.We are licensed for 222 acute care beds and are the second-largest employer in Henderson County. We have several locations separate from our main campus, including a comprehensive physician practice network, three urgent care locations and five orthopedic clinics."

During the past decade, Margaret R Pardee Memorial Hospital conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 107 clinical trials were completed, i.e. on average, 130.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 42 clinical trials were completed. i.e. 420% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Margaret R Pardee Memorial Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "SWOG Cancer Research Network" with 54 trials sponsored, "Alliance for Clinical Trials in Oncology" with 42 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NSABP Foundation Inc" with 10 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Margaret R Pardee Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 136 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator and "Cancer and Leukemia Group B" with 9 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Margaret R Pardee Memorial Hospital" are "Breast Cancer" (29 trials), "Lung Cancer" (17 trials), "Recurrent Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (8 trials). Many other conditions were trialed in "Margaret R Pardee Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Margaret R Pardee Memorial Hospital" are "Drug" (171 trials), "Other" (128 trials), "Biological" (81 trials), "Procedure" (46 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (57 trials), "Quality-of-Life Assessment" (44 trials), "Computed Tomography" (24 trials), "Biospecimen Collection" (22 trials) and "Questionnaire Administration" (22 trials). Other intervention names were less common.

The vast majority of trials in "Margaret R Pardee Memorial Hospital" are 182 trials for "All" genders, 43 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Margaret R Pardee Memorial Hospital". undefined are not yet recruiting, 29 are recruiting, 83 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 99 completed trials in Margaret R Pardee Memorial Hospital, 2 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Margaret R Pardee Memorial Hospital, 12 "Phase 1" clinical trials were conducted, 99 "Phase 2" clinical trials and 112 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".

Margaret R Pardee Memorial Hospital has several departments that took part in Clinical trials: "Hendersonville Hematology and Oncology at Pardee" - 56 trials